Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Sold under brand names such as Ozempic and Wegovy, weight loss injections are “skyrocketing” in popularity, with one in eight people in the US using the drugs to treat heart disease, type 2 diabetes ...

Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Major heart health risk factors like obesity, diabetes and high blood pressure ... risks of GLP-1 weight-loss drugs The report indicates that heart-related deaths appear to be leveling out after ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

Sarah is an experienced writer and editor enthusiastic about helping readers live their healthiest and happiest lives. Before joining Forbes Health, Sarah worked as a writer for various digital ...

Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...